These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 5587721

  • 1. [Eye and skin complications with long-term treatment of psychopharmaceutic agents].
    Gunby B.
    Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721
    [No Abstract] [Full Text] [Related]

  • 2. Toxic effects of phenothiazines on the eye.
    Boet DJ.
    Doc Ophthalmol; 1970 Jul 24; 28(1):1-69. PubMed ID: 5312274
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS, Shader RI, DiMascio A.
    Conn Med; 1970 Jan 24; 34(1):25-8. PubMed ID: 4903792
    [No Abstract] [Full Text] [Related]

  • 5. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments].
    Lambert PA.
    Encephale; 1971 Jan 24; 60(4):335-49. PubMed ID: 5004893
    [No Abstract] [Full Text] [Related]

  • 6. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Jan 24; 69(6):935-9. PubMed ID: 4905472
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An adverse reaction unit: results and functions.
    Ananth JV, Ban TA, Lehmann HE, Rizvi FA.
    Am J Psychiatry; 1971 Apr 24; 127(10):1339-44. PubMed ID: 5092571
    [No Abstract] [Full Text] [Related]

  • 11. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A, Cuendet JF.
    Schweiz Med Wochenschr; 1968 Oct 26; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ocular manifestations during treatment with phenothiazine derivatives].
    Ardouin M, Feuvrier YM, Delattre A.
    Bull Soc Ophtalmol Fr; 1969 Mar 26; 69(3):395-401. PubMed ID: 5383905
    [No Abstract] [Full Text] [Related]

  • 14. Prognosis of eye complications caused by phenothiazines.
    Forrest FM, Snow HL.
    Dis Nerv Syst; 1968 Mar 26; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract] [Full Text] [Related]

  • 15. Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes.
    Edler K, Gottfries CG, Haslund J, Ravn J.
    Acta Psychiatr Scand; 1971 Mar 26; 47(4):377-84. PubMed ID: 5146713
    [No Abstract] [Full Text] [Related]

  • 16. [Ultrastructural study of ocular pigmentation due to phenothiazines].
    Sizaret P, Rossazza C, Brassart B.
    Rev Otoneuroophtalmol; 1975 Mar 26; 47(4):247-51. PubMed ID: 1215727
    [No Abstract] [Full Text] [Related]

  • 17. [Eye pigmentation disorders in patients treated with phenothiazines].
    Sizaret P, Quéré M, Degiovanni E, Degiovanni A.
    Encephale; 1968 Mar 26; 57(6):515-24. PubMed ID: 5730657
    [No Abstract] [Full Text] [Related]

  • 18. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D.
    Dis Nerv Syst; 1968 Mar 26; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract] [Full Text] [Related]

  • 19. LENS AND CORENEA CHANGES DURING PHENOTHIAZINE THERAPY: A PRELIMINARY REPORT.
    BARSA JA, NEWTON JC, SAUNDERS JC.
    Am J Psychiatry; 1965 Sep 26; 122():331-2. PubMed ID: 14327480
    [No Abstract] [Full Text] [Related]

  • 20. Ocular complications of phenothiazines.
    Mathalone MB.
    Trans Ophthalmol Soc U K (1962); 1966 Sep 26; 86():77-88. PubMed ID: 5226613
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.